Bernice Welles

Bernice Welles

Direktor/Vorstandsmitglied bei
American Life Science Pharmaceutical, Inc.
73 Jahre
Health Technology
Consumer Services
Finance

Profil

Bernice R.
Welles
is currently a Director at American Life Science Pharmaceutical, Inc., a Member at The Endocrine Society, and a Partner at IPF Management I SARL. Previously, she worked as the Chief Executive Officer at Alquest Therapeutics, Inc. from 2010 to 2013, Vice President-Product Development at Genentech, Inc. from 1995 to 2003, Vice President-Development at DiObex, Inc. from 2005 to 2008, Chief Medical Officer at Enject, Inc. from 2009 to 2013, and as a Venture Partner at MPM BioImpact, Inc. from 2003 to 2005.
She also served as an Independent Director at Spectrum Pharmaceuticals, Inc. and as Treasurer & Director at The San Francisco Food Bank.
Dr. Welles is a graduate of Brandeis University, Tufts University, Albany Medical College, and The Wharton School of the University of Pennsylvania.

Aktive Positionen von Bernice Welles

UnternehmenPositionBeginn
Corporate Officer/Principal 01.12.2010
Direktor/Vorstandsmitglied -
Private Equity Investor -

Ehemalige bekannte Positionen von Bernice Welles

UnternehmenPositionEnde
Alquest Therapeutics, Inc.
Vorstandsvorsitzender 01.01.2013
Technik-/Wissenschafts-/F&E-Leiter 01.12.2010
Corporate Officer/Principal 01.01.2008
Private Equity Investor 01.04.2005
Corporate Officer/Principal 31.07.2003
Sehen Sie sich die Erfahrung von Bernice Welles im Detail an

Ausbildung von Bernice Welles

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

87

Beziehungen ersten Grades

16

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen16

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Services

Commercial Services

Consumer Services

Health Technology

Consumer Services

Finance

Alquest Therapeutics, Inc.

  1. Börse
  2. Insiders
  3. Bernice Welles